Literature DB >> 5840

Cerebral blood flow and exchange of oxygen, glucose, ketone bodies, lactate, pyruvate and amino acids in infants.

G Settergren, B S Lindblad, B Persson.   

Abstract

Cerebral blood flow (CBF) and cerebral av-differences of oxygen and circulating substrates were measured in normocapnic infants during general anaesthesia before elective surgery in order to study possible age-dependent variations. CBF was determined by a minor modification of the Kety-Schmidt technique from desaturation curves of nitrous oxide (N2O) in arterial and cerebral venous blood (N2O analysed by gas chromatography on 15 mul blood samples) after reduction of inhaled N2O from 75 to 50%. The reproducibility was +/-4.6%. Lactate, pyruvate and oxygen were determined in whole blood and amino acids in plasma by ion-exchange chromatography. Reliable av-differences of glucose, acetoacetate and D-beta-hydroxybutyrate could be calculated from plasma values and hematocrits. Mean values from 12 infants (age 11 days-12 months) were: CBF 69 ml/100 g0min-1; cerebral uptake (in mumoles/100 g-min-1): oxygen 104, glucose 27, acetoacetate 0.9, D-beta-hydroxybutyrate 2.3; cerebral release: lactate 2.4 and pyruvate 0.8. Significant uptake of amino acids was found only for histidine 0.95 and arginine 0.7. Significant correlations between arterial concentration and cerebral exchange were found for: ornithine, arginine, phenylalanine, aspartic acid, serine, glutamine and acetoacetate. CBF and substrate exchange were unrelated to age within the group. Infants had higher mean CBF and greater uptake of ketone bodies than has been reported in adults.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5840     DOI: 10.1111/j.1651-2227.1976.tb04896.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  26 in total

Review 1.  Hypoglycaemia of the newborn: a review.

Authors:  A F Williams
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  Regional aerobic glycolysis in the human brain.

Authors:  S Neil Vaishnavi; Andrei G Vlassenko; Melissa M Rundle; Abraham Z Snyder; Mark A Mintun; Marcus E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

3.  Spring meeting, university hospital of wales, cardiff, 1 and 2 april 1977.

Authors: 
Journal:  Arch Dis Child       Date:  1977-10       Impact factor: 3.791

Review 4.  Cerebral blood flow in the newborn infant.

Authors:  O Pryds; A D Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

5.  Clinical approach to inherited metabolic diseases in the neonatal period: a 20-year survey.

Authors:  J M Saudubray; H Ogier; J P Bonnefont; A Munnich; A Lombes; F Hervé; G Mitchel; B P Thé; N Specola; P Parvy
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 6.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 7.  Metabolic Alterations in Developing Brain After Injury: Knowns and Unknowns.

Authors:  Mary C McKenna; Susanna Scafidi; Courtney L Robertson
Journal:  Neurochem Res       Date:  2015-07-07       Impact factor: 3.996

8.  3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: report of five new patients.

Authors:  K M Gibson; J Breuer; K Kaiser; W L Nyhan; E E McCoy; P Ferreira; C L Greene; M G Blitzer; E Shapira; F Reverte
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

9.  Monocarboxylate Transporter 1 in the Medial Prefrontal Cortex Developmentally Expresses in Oligodendrocytes and Associates with Neuronal Amounts.

Authors:  Mao Zhang; Ziyi Ma; Haochen Qin; Zhongxiang Yao
Journal:  Mol Neurobiol       Date:  2016-03-09       Impact factor: 5.590

Review 10.  Cerebral blood flow and autoregulation after pediatric traumatic brain injury.

Authors:  Yuthana Udomphorn; William M Armstead; Monica S Vavilala
Journal:  Pediatr Neurol       Date:  2008-04       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.